LETTER
Synthesis of Manoyl Oxide Derivatives by TiCl4-Catalyzed Cleavage
2315
(2) (a) Arew, S. V. B. Prog. Chem. Org. Nat. Prod. 1993, 1.
(b) Kopras, E.; Greeley, T.; Babcock, G. F.
The lactone 16, the isolation of which in related processes
has not been reported,14,17 is formed under thermodynam-
ic conditions. Lactone 16 is irreversibly formed from 15,
which is equilibrated with its epimer 14 (Scheme 5). In
support of this supposition is the fact that the treatment of
14 with KCN/ AlEt2CN and TiCl4 at room temperature af-
fords in high yield a 1:1 mixture of acetal 11 and lactone
16.
Gastroenterology 2002, 122, W1096. (c) Yool, A. J.;
Stamer, W. D.; Regan, J. W. Science 1996, 273, 1216.
(d) Robbins, J. D.; Boring, D. L.; Tang, W. J.; Shank, R.;
Seamon, K. B. J. Med. Chem. 1996, 39, 2745. (e) Tang, W.
J.; Gilman, A. G. Science 1995, 268, 1769.
(3) Kalpoutzakis, E.; Aligiannis, N.; Mitaku, S.; Chinou, L.;
Charvala, C.; Skaltsounis, A. L. Chem. Pharm. Bull. 2001,
49, 814.
The manoyl oxide framework of 14 was elaborated in ac-
cordance with the retrosynthetic Scheme 2. Treatment of
14 with DIBAH in THF at room temperature gives in high
yield aldehyde 17, which is converted into the vinyl deriv-
ative 18 after reaction with the methylenphosphorane. Re-
duction of tosyl derivative 19 by refluxing with LiAlH4 in
THF affords 19-hydroxymanoyl oxide 20, diterpene iso-
lated from P. viscosum.18 Spectroscopic properties of 20
are identical to those of the natural compound (Scheme 6).
(4) (a) Skaltsa, H. D.; Lazari, D. M.; Chinou, I. B.; Loukis, A. E.
Planta Med. 1999, 65, 255. (b) Roussis, V.; Tsoukatou, M.;
Chinou, I. B.; Ortiz, A. Planta Med. 1998, 64, 675.
(c) Kalpoutzakis, E.; Chinou, L.; Mitaku, S.; Skaltsounis, A.
L.; Charvala, C. Nat. Prod. Lett. 1998, 11, 173.
(5) García-Granados, A.; Liñán, E.; Martínez, A.; Onorato, M.
E.; Parra, A.; Arias, J. M. Phytochemistry 1995, 38, 287.
(6) Konishi, T.; Takasaki, M.; Tokuda, H.; Kiyosawa, S.;
Konoshima, T. Biol. Pharm. Bull. 2001, 24, 1440.
(7) (a) Dimas, K.; Demetzos, C.; Mitaku, S.; Vaos, B.;
Marselos, M.; Tzavaras, T.; Kokkinopoulos, D. Anticancer
Res. 1999, 19, 4065. (b) Angelopoulou, D.; Demetzos, C.;
Dimas, C.; Perdetzoglou, D.; Loukis, A. Planta Med. 2001,
67, 168. (c) Demetzos, C.; Mitaku, S.; Couladis, M.;
Harvala, C.; Kokkinopoulos, D. Planta Med. 1994, 60, 590.
(8) Garcia Granados, A.; Liñan, E.; Martinez, A.; Rivas, F.;
Mesa Valle, C. M.; Castilla Calvente, J. J.; Osuna, A. J. Nat.
Prod. 1997, 60, 13.
HO
HO
CHO
CN
O
O
(i)
COOMe
COOMe
17
14
(9) Dimas, K.; Demetzos, C.; Vaos, V.; Ioannidis, P.; Trangas,
T. Leukemia Res. 2001, 25, 449.
(ii)
(10) Duan, H.; Takaishi, Y.; Momota, H.; Ohmoto, Y.; Taki, T.;
Jia, Y.; Li, D. J. Nat. Prod. 1999, 62, 1522.
HO
(11) (a) De las Heras, B.; Hoult, J. R. Planta Med. 1994, 60, 501.
(b) De las Heras, B.; Villar, A.; Vivas, J. M.; Hoult, J. R.
Agents Actions 1994, 41, 114. (c) Alcaraz, M. J.; Jiménez,
M. J.; Valverde, S.; Sanz, J.; Rabanal, R. M.; Villar, A. J.
Nat. Prod. 1989, 52, 1088.
R
O
O
(iii)
R1
COOMe
(12) (a) Fraga, B. M.; Hernández, M. G.; González, P.; López,
M.; Suárez, S. Tetrahedron 2001, 57, 761. (b) Fraga, B. M.;
González, P.; Hernández, M. G.; López, M.; Suárez, S.
Tetrahedron 1999, 55, 1781. (c) Fraga, B. M.; González, P.;
Guillermo, R.; Hernández, M. G. J. Nat. Prod. 1998, 61,
1237. (d) Fraga, B. M.; González, P.; Guillermo, R.;
Hernández, M. G. Tetrahedron 1998, 54, 6159. (e) García-
Granados, A.; Liñán, E.; Martínez, A.; Onorato, M. E.;
Arias, J. M. J. Nat. Prod. 1995, 58, 1695. (f) Amate, Y.;
García-Granados, A.; López, F. A.; Sáenz Buruaga, A.
Synthesis 1991, 371.
(13) Barrero, A. F.; Alvarez-Manzaneda, E. J.; Alvarez-
Manzaneda, R.; Chahboun, R.; Meneses, R.; Aparicio, M.
Synlett 1999, 713.
(14) Rychnovsky, S. D.; Dahanukar, V. H. Tetrahedron Lett.
1996, 37, 339.
(15) (a) Kotsuki, H.; Ushio, Y.; Kadota, I.; Ochi, M. Chem. Lett.
1988, 927. (b) Kotsuki, H.; Ushio, Y.; Kadota, I.; Ochi, M.
J. Org. Chem. 1989, 54, 5153. (c) Kotsuki, H. Synlett 1992,
97. (d) Ishihara, K.; Mori, A.; Yamamoto, H. Tetrahedron
Lett. 1987, 28, 6613. (e) Ishihara, K.; Mori, A.; Yamamoto,
H. Tetrahedron 1990, 46, 4595. (f) Kim, Y.; Mundy, B. P. J.
Org. Chem. 1982, 47, 3556. (g) Masaki, Y.; Serizawa, Y.;
Nagata, K.; Kaji, K. Chem. Lett. 1983, 1601. (h) Lewis, M.
D.; Cha, J. K.; Kishi, Y. J. Am. Chem. Soc. 1982, 104, 4976.
(i) Fotsch, C. H.; Chamberlin, A. R. J. Org. Chem. 1991, 56,
4141.
18
19 R: CH2OTs; R1: COOMe
20 R: Me; R1: CH2OH
(iv)
Scheme 6 (i) DIBALH, THF, 0 ºC–r.t., 1 h (80%). (ii) MePPh3Br,
n-BuLi, THF, 0 ºC, 45 min (80–90%). (iii) TsCl, Pyridine, r.t., 24 h
(95%). (iv) LiAlH4, THF, reflux, 48 h (50%).
In summary, the highly diastereoselective Lewis acid cat-
alyzed cyanoaddition of 11 enables the synthesis of
manoyl oxide derivatives from communic acids 7a–c.
Acknowledgment
We thank DGESEIC for financial support (Project PB98-1365) and
Ministerio de Educación y Ciencia for a pre-doctoral fellowship
(J. L. Romera).
References
(1) (a) Leclaire, M.; Levet, R.; Ferreira, F.; Ducrate, P.-H.;
Ricard, J.-Y. L. L. Chem. Commun. 2000, 18, 1737.
(b) Hanna, I.; Wlodyka, P. J. Org. Chem. 1997, 62, 6985.
(c) Nicolau, K. C.; Kubota, S.; Li, W. S. Chem. Commun.
1989, 512. (d) Corey, E. J.; Da Silva Jardine, P.; Rohloff, J.
C. J. Am. Chem. Soc. 1988, 110, 3672.
(16) Barrero, A. F.; Altarejos, J.; Alvarez-Manzaneda, E. J.;
Ramos, J. M.; Salido, S. Tetrahedron 1993, 49, 9525.
Synlett 2003, No. 15, 2313–2316 © Thieme Stuttgart · New York